Size-dependent effect of zinc oxide on toxicity and inflammatory potential of human monocytes

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 77, Issue 4, 2014, Pages 177-191

  Sahu, Devashri ^a   Kannan, G M ^a   Vijayaraghavan, R ^b  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

^b SAVEETHA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; DNA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; ZINC OXIDE;

ARTICLE; CELL PHAGOCYTOSIS; CELL SIZE; CELL STIMULATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; MONOCYTE; MTT ASSAY; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CELL LINE; CELL SURVIVAL; CHEMOKINE CCL2; CYCLOOXYGENASE 2; CYTOKINES; DNA DAMAGE; ENZYME INDUCTION; HUMANS; IMMUNITY, INNATE; KINETICS; METAL NANOPARTICLES; MICROSPHERES; MONOCYTES; MUTAGENS; PARTICLE SIZE; PHAGOCYTOSIS; RNA, MESSENGER; SURFACE PROPERTIES; UP-REGULATION; ZINC OXIDE;

EID: 84896714721     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2013.853224     Document Type: Article

References (60)

1. Allen, R. T., Hunter, W. J. 3rd, and Agrawal, D. K. 1997. M orphological and biochemical characterization and analysis of apoptosis. J. Pharmacol. Toxicol. Methods 37: 215-228.
2. Applerot, G., Lipovsky, A., Dror, R., Perkas, N., Nitzan, Y., Lubart, R., and Gedanken, A. 2009. Enhanced antibacterial activity of nanocrystalline ZnO due to increased ROSmediated cell injury. Adv. Funct. Mater. 19: 842-852.
3. Beyerle, A., Schulz, H., Kissel, T., and Stoeger, T. 2009. Screening strategy to avoid toxicological hazards of inhaled nanoparticles for drug delivery: The use of a-quartz and nano zinc oxide particles as benchmark. J. Phys. Conf. Ser. 151: 012034.
4. Bunn, H.J., Dinsdale, D., Smith, T., and Grigg, J. 2001. Ultrafine particles in alveolar macrophages from normal children. Thorax 56: 932-934.
5. Collins, A. R. 2004. The comet assay for DNA damage and repair: Principles, applications, andlimitations.Mol.Biotechnol.26:249-261.
6. Churg, A., Gilks, B., and Dai, J. 1999. Induction of fibrogenic mediators by fine and ultrafine titanium dioxide in rat tracheal explants. Am. J. Physiol. 277: L975-L982.
7. Denizot, F., and Lang, R. 1986. Rapid colorimetric assay for cell growth and survival: Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89: 271-277.
8. Diaz, A., Chepenik, K. P., Korn, J. H., Reginato, A. M., and Jimenez, S. A. 1998. Differential regulation of cyclooxygenases 1 and 2 by interleukin 1 beta, tumor necrosis factoralpha, and transforming growth factor-beta 1 in human lung fibroblasts. Exp. Cell. Res. 241: 222-229.
9. Dobrovolskaia, M. A., and McNeil, S. E. 2007 . Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2: 469-478.
10. Dobrovolskaia, M. A., Germolec, D. R., and Weaver, J. L. 2009. Evaluation of nanoparticle immunotoxicity. Nat. Nanotechnol. 4: 411-414.
11. Dobrovolskaia, M. A., Aggarwal, P., Hall, J. B., and McNeil, S. E. 2008. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol. Pharmacol. 5: 487-495.
12. Donaldson, K., and Tran, C. L. 2002. Inflammation caused by particles and fibers. Inhal. Toxicol. 14:5-27.
13. Donaldson, K., Brown, D., Coulter, A., Duffin, R., MacNee, W., Renwick, L., Tran, L., and Stone, V. 2002. The pulmonary toxicology of ultrafine particles. J. Aerosol. Med. 15: 213-220.
14. Elsabahy, M., and Wooley K. L. 201 3. Cytokines as biomarkers of nanoparticle immunotoxicity. Chem. Soc. Rev. 42: 5555-5576.
15. Evans, J. R., Helmy, A. E., Cluroe, A., and Purushotham, A. D. 2004. Lymphoma of the breast-case report and review of the literature. J. BUON 9: 307-311.
16. Ferin, J., Oberdorster, G., and Penney, D. P. 1992. Pulmonary retention of ultrafine and fine particles in rats. Am. J. Respir. Cell Mol. Biol. 6: 535-542.
17. Ferin, J., Oberdorster, G., Penney, D. P., Soderholm, S. C., Gelein, R., and Piper, H. C. 1990. Increased pulmonary toxicity of ultrafines I. Particle clearance, translocation, morphology. J. Aerosol. Sci. 21: 381-384.
18. Ferin, J., Oberdorster, G., Soderholm, S. C., and Gelein, R. 1991. Pulmonary tissue access of ultrafine particles. J. Aerosol. Med. 4:57-68.
19. Gojova, A., Guo, B., Kota, R. S., Rutledge, J. C., Kennedy, I. M., and Barakat, A. I. 2007. Induction of Inflammation in vascular endothelial cells by metal oxide nanoparticles: Effect of particle composition. Environ. Health. Perspect. 115: 403-409.
20. Grandjean-Laquerriere, A., Laquerriere, P., Guenounou, M., Laurent-Maquin, D., and Phillips, T.M. 2005. Importance of the surface area ratio on cytokines production by human monocytes in vitro induced by various hydroxyapatite particles. Biomaterials 26: 2361-2369.
21. Groves, D. T., and Jiang, Y. 1995. Chemokine, a family of chemotactic cytokines. Crit. Rev. Oral Biol. Med. 6: 109-118.
22. Gulumian, M., and Vallyathan, V. 2010. Nanoparticles and potential human health implications: Past a nd future directions. Preface. J. Toxicol. Environ. Health A 73: 339-340.
23. Hanley, C., Hurber, A., Hanna, C., Punnoose, A., Zhang, J., and Wingett, D. G. 2009. The influences of cell type and ZnO nanoparticle size on immune cell cytotoxicity and cytokine induction. Nanoscale Res. Lett. 4: 1409-1420.
24. He, Y. T., Wan, J., and Tokunaga, T. 2008. Kinetic stability of hematite nanoparticles: The effect of particle sizes. J. Nanopart. Res. 10: 321-332.
25. Heng, B. C., Zhao, X., Tan, E.C., Khamis, N., Assodani, A., Xiong, S., Ruedl, C., Ng, K. W., and Loo, J. S. 2011. Evaluation of the cytotoxic and inflammatory potential of differentially shaped zinc oxide nanoparticles. Arch. Toxicol. 85: 1517-1528.
26. Hollingsworth, J. W., Maruoka, S., Li, Z., Potts, E. N., Brass, D. M., Garantziotis, S., Fong A., Foster, W. M., and Schwartz, D. A. 2007. Ambient ozone primes pulmonary innate immunity in mice. J. Immunol. 179: 4367-4375.
27. Hong, H., Shi, J., Yang, Y., Zhang, Y., Engle, J. W., Nickles, R. J., Wang, X., and Cai, W. 2011. Cancer-targeted optical imaging with fluorescent zinc oxide nanowires. Nano Lett. 11: 3744-3750.
28. Huber, A., Kunkel, S., Todd, R. 3rd, and Weiss, S., 1991. Regulation of t ransendothelial neutrophil migration by endogenous interleukin-8. Science 254: 99-102.
29. Hussain, S., Vanoirbeek, J. A., and Hoet, P. H. 2012. Interactions of nanomaterials with the immune system. Nanomed. Nanobiotechnol. 4: 169-183.
30. Hussain, S., Vanoirbeek, J. A., Luyts, K., De Vooght, V., Verbeken, E., Thomassen, L. C., Martens, J. A., Dinsdale, D., Boland, S., Marano, F., Nemery, B., and Hoet, P. H. 2011. Lung exposure to nanoparticles modulates an asthmatic response in a mouse model. Eur. Respir. J. 37: 299-309.
31. Inoue, K., Takano, H., Yanagisawa, R., Hirano, S., Sakurai, M., Shimada, A., and Yoshikawa, T. 2006. Effects of airway exposure to nanoparticles on lung inflammation induced by bacterial endotoxin in mice. Environ. Health Perspect. 114: 1325-1330.
32. Kamata, H., Tasaka, S., Inoue, K., Miyamoto, K., Nakano, Y., Shinoda, H., Kimizuka, Y., Fujiwara, H., Ishii, M., Hasegawa, N., Takamiya, R., Fujishima, S., Takano, H., and Ishizaka, A. 2011. Carbon black nanoparticles enhance bleomycin-induced lung inflammatory and fibrotic changes in mice. Exp. Biol. Med. (Maywood) 236: 315-324.
33. Kim, J. E., Lim, H. T., Minai Tehrani, A., Kwon, J. T., Shin, J. Y., Woo, C. G., Choi, M., Back, J., Jeong, D. J., Ha, Y. C., Chae, C. H., Song, K. S., Ahn, K. H., Lee, J., H., Sung, H. J., Yu, I. J., Beck, G. R, and Cho, M. H. 2010. Toxicity and clearance of intratracheally administered multiwalled carbon nanotubes from muine lung. J. Toxicol Environ. Health A 73: 1530-1543.
34. LeBlanc, A. J., Crumpston, J. L., Chen, B. T., Frazer, D., Castranova, V., and Nurkiewicz, T. R. 2009. Nanoparticle inhalation impairs endothelium-dependent vasodilation in subepicardial arterioles. J. Toxicol. Environ. Health A 72: 1576-1584.
35. Lee, H. M., Shin, D. M., Song, H. M., Yuk, J. M., Lee, Z. W., Lee, S. H., Hwang, S. M., Kim, J. M., Lee, C. S., and Jo, E. K. 2009. Nanoparticles up-regulate tumor necrosis factor-alpha and CXCL8 via reactive oxygen species and mitogen-activated protein kinase activation. Toxicol. Ap pl. Pharmacol. 238: 160-169.
36. Li, X. Y., Brown, D., Smith, S., MacNee,W., and Donaldson, K. 1999. Short-term inflammatory responses following intratracheal instillation of fine and ultrafine carbon black in rats. Inhal. Toxicol. 11: 709-731.
37. Li, X. Y., Gilmour, P. S., Donaldson, K., and MacNee, W. 1996. Free radical activity and pro-inflammatory effects of particulate air pollution (PM10) in vivo and in vitro. Thorax 51: 1216-1222.
38. Manzo, N. D., Slade, R., Richards, J. H.,McKee, J. K., Martin, L. D., and Dye, J. A. 2010. Susceptibility of inflamed alveolar and airway epithelial cells to injury induced by diesel exhaust of particles of varying organic carbon content. J. Toxicol. Environ. Health A 73: 565-580.
39. Maynard, A. D., Baron, P. A., Foley, M., Shvedova, A. A., Kisin, E. R., and Castranova, V. 2004. Expo sure to carbon nanotube material: Aerosol release during the handling of unrefined single-walled carbon nanotube material. J. Toxicol. Environ. Health A 67: 87-107.
40. Nag, N., Bhattacharya, A., Gupta, R.K., Manivannan, K., Kahol, P.K., Wanekaya, A. K., Delong, R. K., and Ghosh, K. 2011. Glucose stabilized ZnO nanoparticles for biomedical applications. J. Nanosci. Lett. 1: 172-178.
41. Nicholas, S. A., and Sumbayev, W. 2009 . The involvement of hypoxia-inducible factor 1 alpha in Toll-like receptor 7/8-mediated inflammatory response. Cell Res. 19: 973-983.
42. Oberdorster, G. 2001. Pulmonary effects of inhaled ultrafine particles. Int. Arch. Occup. Environ. Health 74: 1-8.
43. Osmond, M. J., and McCall, M. J. 2010. Zinc oxide nanoparticles in modern sunscreens: An analysis of potential exposure and hazard. Nanotoxicology 4: 15-41.
44. Petosa, A. R., Jaisi, D. P., Quevedo, I. R., Elimelech, M., and Tufenkji, N. 2010. Aggregation and deposition of engineered nanomaterials in aquatic environments: Role of physicochemical interactions. Environ. Sci. Technol. 44: 6532-6549.
45. Pope, C. A. 3rd, Thun, M. J., Namboodiri, M. M., Dockery, D. W., Evans, J. S., Speizer, F. E., and Heath, C. W., Jr. 1995. Particulate air pollution as a predictor of mortality in a prospective study of US adults. Am. J. Respir. Crit. Care Med. 151: 669-674.
46. Prach, M., Stone, V., and Proudfoot, L. 2012. Zinc oxide nanoparticles and monocytes: Impact of size, charge and solubility on activation status. Toxicol. Appl. Pharmacol. 266: 19-26.
47. Price, H., Arthur, R., Sexton, K., Gregory, C., Hoogendoorn, B., Matthews, I., Jones, T., and BeruBe, K. 2010. Airborne particles in Swansea, UK: Their collection and characterization. J. Toxicol. Environ. Health A 73: 355-367.
48. Rasmussen, J. W., Martinez, E., Louka, P., and Wingett, D. G. 2010. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin. Drug. Deliv. 7: 1063-1077.
49. Reddy, M. C., Subhashini, J., Mahipal, S. V. K., Bhat, V. B., Reddy, P. S., Kiranmai, G., Madyasatha, K. M., and Reddanna, P. 2003. C-phycocyanin, a selective cyclooxygenase-2 inhibitor, induces apoptosis in lipopolysaccharide- stimulated RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 304: 385-392.
50. Sayes, C. M., Reed, K. L., and Warhiet, D. B. 2007. Assessing toxicity of fin e and nanoparticles: Comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol. Sci. 97: 163-180.
51. Scuri, M., Chen, B. T., Castranova, V., Reynolds, J. S., Johnson, V. J., Samsell, L., Watson, C., and Piedimonte, G. 2010. Effects of titanium dioxide nanoparticle exposure on neuroimmune responses in rat airways. J. Toxicol. Environ. Health A 73: 1353-1369.
52. Schroeder, F., and Kinden, D. A. 1983. Measurement of phagocytosis using fluorescent latex beads. J. Biochem. Biophys. Methods 8: 15-27.
53. Tabet, L., Bussy, C., Amara, N., Setyan, A., Grodet, A., Rossi, M. J., Pairon, J. C., Boczkowski, J., and Lanone, S. 2009. Adverse effects of industrial multiwalled carbon nanotubes on human pulmonary cells. J. Toxicol. Environ. Health A 72: 60-73.
54. Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T., and Tada, K. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26: 171-176.
55. Veranth, J. M., Kaser, E. G., Veranth, M. M., Koch, M., and Yost, G. S. 2007. Cytokine responses of human lung cells (BEAS-2B) treated with micron-sized and nanoparticles of metal oxides compared to soil dusts. Part. Fibre Toxicol. 4: 2.
56. Wan, R., Mo, Y., Zhang, X., Chien, S., Tollerud, D. J., and Zhang, Q. 2008. Matrixmetalloproteinase-2 and-9 are induced differently by metal nanoparticles inhuman monocytes: The role of oxidative stress and protein tyrosine kinase activation. Toxicol. Appl. Pharmcol. 233: 276-285.
57. Wroblewski, F., and LaDue, J. S. 1955. Lactic dehydrogenase activity in blood. Proc. Soc. Exp. Biol. Med. 90: 210-213.
58. Yang, Z., and Xie, C. 2006. Zn2+ release from zinc and zinc oxide particles in simulated uterine solution. Colloids Surfact. B Biointerfaces 47: 140-145.
59. Zhao, J., and Castranova, V. 2011. Toxicology of nanomaterials used in nanomedicine. J. Toxicol. Environ. Health B 14: 593-632.
60. Zolnik, B. S., Gonzalez-Fernandez, A., Sadrieh, N., and Dobrovolskaia, M. A. 2010. Nanoparticles and the immune system. Endocrinology 151: 458-465.